The National Cancer Institute (NCI) awarded a $1,239,420 Project Grant (CFDA 93.393 - Cancer Cause and Prevention Research) to the University of Maryland, Baltimore to conduct a longitudinal observational study on the role of interoception in chemotherapy-induced peripheral neuropathy (CIPN) in breast and gastrointestinal cancer patients. The 5-year study will assess changes in interoception - the brain's processing of bodily sensations - before, during, and after chemotherapy, and evaluate...
This $1,902,238 Project Grant award, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research program, will support research to characterize the relationships between genetic risk factors, parental feeding practices, children's appetitive traits, and adiposity gain across early childhood. The primary goals are to understand how coercive parental feeding practices like food restriction...
This $166,000 federal Project Grant award from the National Cancer Institute's Cancer Detection and Diagnosis Research program (CFDA 93.394) will support research to examine whether implicit attitudes towards physical activity can be experimentally manipulated through affect-based intervention strategies delivered via interactive mobile technology. The University of Southern California is the prime awardee and will explore how real-time measures of implicit attitudes during daily life among...
This $142,295 Project Grant was awarded on May 1, 2025 by the National Cancer Institute under the Cancer Research Manpower (CFDA 93.398) federal grant program. The grant will fund research to identify gut microbial and metabolomic biomarkers associated with the relationship between ultra-processed foods and colorectal cancer risk, as well as evaluate the feasibility and initial efficacy of a medically tailored meal intervention to improve survivorship among colorectal cancer patients. The...
This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) to the Sloan-Kettering Institute for Cancer Research totals $794,530 over 5 years beginning September 1, 2024. The funding will support a Phase IIB randomized controlled trial to determine the efficacy of time-restricted eating in reducing weight and cardiometabolic risk among 300 radiation-exposed survivors of childhood cancer with overweight/obesity. The trial will assess the...
The National Cancer Institute (NCI) awarded a $405,316 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to The Ohio State University. The grant, titled "Role of the Inflammatory Dietary Pattern in Gut and Colon Tissue Microbiomes and Impact on Survival Outcomes Among Colorectal Cancer Patients," will run from June 1, 2024 to May 31, 2026.
The project aims to identify gut microbes associated with an inflammatory dietary pattern (as measured by the...
The National Cancer Institute (NCI) awarded a $455,111 Project Grant under CFDA 93.393 "Cancer Cause and Prevention Research" to the Sloan-Kettering Institute for Cancer Research in New York. The 2-year grant, awarded on September 5, 2023, will support research to "Leverage the Hidden Genome to Recover the Missing Heritability of Cancer." The project aims to 1) estimate additional heritability that can be explained by the "hidden genome" (regions of unknown...
This $543,322 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports research on targeting olfactory neural pathways to combat obesity. The key objectives are to:
Determine the physiological relevance of food odor-responsive neurons in the ventral subiculum (VSUB) in regulating food intake, including analyzing the transcriptomic features of...
The National Cancer Institute (NCI) awarded a $621,732 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to the Medical University of South Carolina (MUSC). The 5-year grant, awarded on August 1, 2024, will fund research to comprehensively assess the effectiveness of a proactive identification and digital mental health intervention approach to address unmet psychosocial needs of individuals living with likely incurable cancer. The project aims to develop an...
This Project Grant award, with a total of $615,411 in funding, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports research at the University of Georgia Research Foundation to investigate how adolescent consumption of a "Western diet" high in saturated fat and added sugars impacts the development of impulsive eating behaviors.
Key...
The National Cancer Institute (NCI) awarded a $412,171 Project Grant (CFDA 93.393 - Cancer Cause and Prevention Research) to The Pennsylvania State University (Penn State) to better understand how individual differences in interoception, the process of sensing and interpreting internal bodily states, contribute to non-homeostatic eating behaviors in children aged 7-10 years. The project aims to examine the relationship between interoceptive awareness, ghrelin and leptin signaling, and the propensity for eating in the absence of hunger. This research seeks to reveal how interoceptive function impacts food intake and establish a foundation for tailored intervention strategies targeting childhood obesity and associated cancer risk factors. The project will be conducted at Penn State over a 2-year period from June 2024 to May 2026.